IMPLANTACIJA MICRA MINIJATURNOG PEJSMEJKERA BEZ ELEKTRODA: ISKUSTVO I SERIJA SLUČAJEVA

  • Tomislav Kostić 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Zoran Perišić 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Svetlana Apostolović 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Sonja Dakić 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Dragana Stanojevic Klinički Centar Niš, Klinika za kardiovaskularne bolesti
  • Nenad Božinović 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Bojan Maričić 1- Clinic for cardiology, University Clinical Center Niš, Serbia
  • Danijela Đorđević-Radojković 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Goran Koraćević 1- Clinic for cardiology, University Clinical Center Niš, Serbia 2- Medical Faculty, University of Niš, Serbia
  • Predrag Cvetković 1- Clinic for cardiology, University Clinical Center Niš, Serbia
  • Miroslav Nikolić 1- Clinic for cardiology, University Clinical Center Niš, Serbia
  • Katarina Kostić 1- Clinic for cardiology, University Clinical Center Niš, Serbia
  • Mihajlo Bojanović 1- Clinic for cardiology, University Clinical Center Niš, Serbia
Ključne reči: Micra pejsmejker, ugradnja pejsmejkera, komplikacije

Sažetak


Napredak tehnologije i medicine doneo je nova rešenja za izazove sa kojima se medicinski radnici susreću u svakodnevnoj praksi. Nakon ugradnje prvog epikardijalnog pejsmejkera pre oko pola veka, proces tehničkog napretka i minijaturizacije uređaja rezultirao je najnovijom generacijom veštačkih vodiča srca (VVS), koji uz pomoć sofisticirane tehnologije prevazilazi prepreke konvencionalnih uređaja. Micra pejsmejker je jednokomorni uređaj težak dva grama, čija zapremina iznosi 0,8 cm2. U obliku je kapsule, ima dužinu od 25,9 mm i spoljašnji prečnik od 6,7 mm. Ne samo da veličina uređaja ne ograničava funkcije uređaja već i predstavlja značajnu prednost i novinu u svetu implantabilnih uređaja.

U ovom radu je prikazana serija prvih šest slučajeva transkateterske transvenske implantacije minijaturnog aparata, odnosno pejsmejkera Medtronic Micra (Medtronic, Minesota, SAD) za trajnu srčanu stimulaciju u Univerzitetskom kliničkom centru u Nišu.

Micra sistem bez elektroda pokazao se u praksi kao bezbedna i efikasna opcija za trajni pejsing kod odraslih bolesnika. Kod pojedinih bolesnika kod kojih uobičajeni venski pristup nije moguć (zbog višestruke sternotomije, toraktomije, urođene ili stečene anomalije) postao je najkorisnija alternativa u slučaju indikacije za trajni pejsing.

Reference

Breatnach CR, Dunne L, Al-Alawi K, Oslizlok P, Kenny D, Walsh KP. Leadless micra pacemaker use in the pediatric population: device implantation and short-term outcomes. Pediatr Cardiol 2020; 41(4):683–6. [CrossRef] [PubMed]

Duray GZ, Ritter P, El-Chami M, Narasimhan C, Omar R, Tolosana JM, et al. Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study. Heart Rhythm 2017;14(5):702-9. [CrossRef] [PubMed]

El-Chami MF, Al-Samadi F, Clementy N, Garweg C, Martinez-Sande JL, Piccini JP, et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm 2018;15(12):1800-7. [CrossRef] [PubMed]

Grabowski M, Michalak M, Gawałko M, Gajda S, Cacko A, Januszkiewicz Ł, et al. Implantation of the Micra transcatheter pacing system: Single Polish center experience with the real costs of hospitalization analysis. Cardiol J 2020;27(1):47-53. [CrossRef] [PubMed]

Johar S, Luqman N. Initial experience with a leadless pacemaker (Micra™) implantation in a low volume center in South East Asia. Future Cardiol 2018;14(5):389-95. [CrossRef] [PubMed]

Kypta A, Blessberger H, Kammler J, Lambert T, Lichtenauer M, Brandstaetter W, et al. Leadless cardiac pacemaker implantation after lead extraction in patients with severe device infection. J Cardiovasc Electrophysiol 2016;27(9):1067–71. [CrossRef] [PubMed]

Mahapatra S, Bybee KA, Bunch TJ et al. Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm 2005;2(9): 907–11. [CrossRef] [PubMed]

Piccini JP, Stromberg K, Jackson KP, Kowal RC, Duray GZ, El-Chami MF, et al. Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing. Europace 2019;21(11):1686-93. [CrossRef] [PubMed]

Reynolds D, Duray G, Omar R, Soejima K, Neuzil P, Zhang S, et al. A Leadless Intracardiac Transcatheter Pacing System. N Engl J Med 2016; 374(6): 533–41. [CrossRef] [PubMed]

Ritter P, Duray GZ, Steinwender C, Soejima K, Omar R, Mont L, et al. Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing Study. Eur Heart J 2015;36(37):2510–9. [CrossRef] [PubMed]

Shah MJ, Borquez AA, Cortez D, McCanta AC, De Filippo P, Whitehill RD, et al. Transcatheter Leadless Pacing in Children: A PACES Collaborative Study in the Real-World Setting. Circ Arrhythm Electrophysiol 2023;16(4):e011447. [CrossRef] [PubMed]

Sohail MR, Hussain S, Khan HA, Friedman AP, Hayes LD, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49(18):1851–9. [CrossRef] [PubMed]

Study Details | Micra Transcatheter Pacing Study | ClinicalTrials.gov [Last accesed: 09.12.2023.]

Udo EO, Zuithoff NP, Van Hemel NM, de Cock CC, Hendriks T, Doevendans AP, et al. Incidence and predictors of short-and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm 2012;9: 728–35. [CrossRef] [PubMed]

Objavljeno
2025/07/01
Broj časopisa
Vol. 64 Br. 1 (2025): Acta medica Medianae
Rubrika
Originalni rad